Clinical Trials Browser

OTHER × Colonic Neoplasms × envafolimab × Clear all

NCT06014372 2024-04-12

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms